192 related articles for article (PubMed ID: 3847470)
1. Drug stop: newer beta-lactam antimicrobials.
McCloskey WW; Jeffrey LP
J Neurosurg Nurs; 1985 Jun; 17(3):210-4. PubMed ID: 3847470
[TBL] [Abstract][Full Text] [Related]
2. Antibiotic use in neonatal sepsis.
Yurdakök M
Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468
[TBL] [Abstract][Full Text] [Related]
3. [The treatment of bacterial infections with the newer antibiotics].
Schley G; Wenzel H
Med Klin; 1981 Mar; 76(7):200-7. PubMed ID: 6971983
[No Abstract] [Full Text] [Related]
4. [Piperacillin/tazobactam--Tazocin. A penicillin-based alternative to 3rd generation cephalosporins and carbapenems].
Schønning K; Tvede M
Ugeskr Laeger; 2002 May; 164(20):2606-10. PubMed ID: 12043402
[TBL] [Abstract][Full Text] [Related]
5. Role of newer broad-spectrum beta-lactam and fluoroquinolone antibiotics in children.
Bonafede ME; Blumer JL
Adv Pediatr Infect Dis; 1996; 12():71-108. PubMed ID: 9033976
[No Abstract] [Full Text] [Related]
6. The expanding spectrum of beta-lactam antibiotics.
Allan JD; Eliopoulos GM; Moellering RC
Adv Intern Med; 1986; 31():119-46. PubMed ID: 3511613
[No Abstract] [Full Text] [Related]
7. The role of newer antibiotics in gastroenterology.
Li E; Stanley SL
Gastroenterol Clin North Am; 1992 Sep; 21(3):613-29. PubMed ID: 1516960
[TBL] [Abstract][Full Text] [Related]
8. The use of beta-lactam antibiotics in infections--an overview.
Quintiliani R
Scand J Infect Dis Suppl; 1984; 42():99-109. PubMed ID: 6597565
[TBL] [Abstract][Full Text] [Related]
9. [Review of oral cephalosporins. Basis for a rational choice].
Forti IN
Medicina (B Aires); 1994; 54(5 Pt 1):439-58. PubMed ID: 7658980
[TBL] [Abstract][Full Text] [Related]
10. Role of newer antimicrobial agents in the treatment of mixed aerobic and anaerobic infections.
Karam GH; Sanders CV; Aldridge KE
Surg Gynecol Obstet; 1991; 172 Suppl():57-64. PubMed ID: 2024228
[TBL] [Abstract][Full Text] [Related]
11. Recent developments in antimicrobial therapy with beta-lactam antibiotics.
Beam TR
J Med; 1983; 14(4):307-36. PubMed ID: 6368719
[TBL] [Abstract][Full Text] [Related]
12. [Beta-lactam antibiotics].
Suárez C; Gudiol F
Enferm Infecc Microbiol Clin; 2009 Feb; 27(2):116-29. PubMed ID: 19254642
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial therapy.
McCue JD
Clin Geriatr Med; 1992 Nov; 8(4):925-45. PubMed ID: 1423144
[TBL] [Abstract][Full Text] [Related]
14. Antibiotic combinations for the empiric treatment of the febrile neutropenic patient.
Walsh TJ; Schimpff SC
Schweiz Med Wochenschr Suppl; 1983; 14():58-63. PubMed ID: 6361993
[TBL] [Abstract][Full Text] [Related]
15. Appropriate prescribing of oral beta-lactam antibiotics.
Holten KB; Onusko EM
Am Fam Physician; 2000 Aug; 62(3):611-20. PubMed ID: 10950216
[TBL] [Abstract][Full Text] [Related]
16. Effect of aminoglycoside and beta-lactam combination therapy versus beta-lactam monotherapy on the emergence of antimicrobial resistance: a meta-analysis of randomized, controlled trials.
Bliziotis IA; Samonis G; Vardakas KZ; Chrysanthopoulou S; Falagas ME
Clin Infect Dis; 2005 Jul; 41(2):149-58. PubMed ID: 15983909
[TBL] [Abstract][Full Text] [Related]
17. Clinical relevance of antimicrobial resistance in the management of pneumococcal community-acquired pneumonia.
Feldman C
J Lab Clin Med; 2004 May; 143(5):269-83. PubMed ID: 15122171
[TBL] [Abstract][Full Text] [Related]
18. Community-acquired lower respiratory tract infections: clinical experience with beta-lactam/beta-lactamase inhibitors.
Lode H
Int J Clin Pract Suppl; 2002 Mar; (125):10-17; discussion 37-9. PubMed ID: 12014852
[TBL] [Abstract][Full Text] [Related]
19. Beta-lactam antibiotics: newer formulations and newer agents.
Martin SI; Kaye KM
Infect Dis Clin North Am; 2004 Sep; 18(3):603-19, ix. PubMed ID: 15308278
[TBL] [Abstract][Full Text] [Related]
20. Bacterial resistance mechanisms to beta-lactam antibiotics: assessment of management strategies.
Dudley M
Pharmacotherapy; 1995; 15(1 Pt 2):9S-14S. PubMed ID: 7753692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
